Poor rhinitis and asthma control is associated with decreased health-related quality-of-life and utilities : A MASK-air study
Copyright © 2024. Published by Elsevier Inc..
BACKGROUND: Allergic rhinitis (AR) and asthma may impact health-related quality-of-life. However, national estimates on the quality-of-life of patients with AR or asthma are lacking.
OBJECTIVE: To provide estimates for utility scores and EQ-5D Visual Analog Scale (VAS) for patients with AR or asthma.
METHODS: We conducted a cross-sectional study using direct patient data from the MASK-air® app on European MASK-air® users with self-reported AR or asthma. We used a multiattribute instrument (EQ-5D) to measure quality-of-life (as utility scores and EQ-5D VAS values). Mean scores were calculated per country and disease control level using multilevel regression models with post-stratification, accounting for age and sex biases.
RESULTS: We assessed data from up to 7905 MASK-air® users reporting a total of up to 82,737 days. For AR, utilities ranged from 0.86-0.99 for good control versus 0.72-0.85 for poor control; EQ-5D VAS levels ranged from 78.9-87.9 for good control versus 55.3-64.2 for poor control. For asthma, utilities ranged from 0.84-0.97 for good control versus 0.73-0.87 for poor control; EQ-5D VAS levels ranged from 68.4-81.5 for good control versus 51.4-64.2 for poor control. Poor disease control was associated with a mean loss of 0.14 utilities for both AR and asthma. For the same control levels, AR and asthma were associated with similar utilities and EQ-5D VAS levels. However, lower values were observed for asthma+AR when compared to AR alone.
CONCLUSION: Poor AR or asthma control are associated with reduced quality-of-life. The estimates obtained from mHealth data may provide valuable insights for health technology assessment studies.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
The journal of allergy and clinical immunology. In practice - (2024) vom: 30. März |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Vieira, Rafael José [VerfasserIn] |
---|
Links: |
---|
Themen: |
Allergic rhinitis |
---|
Anmerkungen: |
Date Revised 01.04.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1016/j.jaip.2024.03.036 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370506383 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM370506383 | ||
003 | DE-627 | ||
005 | 20240403001343.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240403s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jaip.2024.03.036 |2 doi | |
028 | 5 | 2 | |a pubmed24n1361.xml |
035 | |a (DE-627)NLM370506383 | ||
035 | |a (NLM)38561141 | ||
035 | |a (PII)S2213-2198(24)00329-5 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Vieira, Rafael José |e verfasserin |4 aut | |
245 | 1 | 0 | |a Poor rhinitis and asthma control is associated with decreased health-related quality-of-life and utilities |b A MASK-air study |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 01.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Copyright © 2024. Published by Elsevier Inc. | ||
520 | |a BACKGROUND: Allergic rhinitis (AR) and asthma may impact health-related quality-of-life. However, national estimates on the quality-of-life of patients with AR or asthma are lacking | ||
520 | |a OBJECTIVE: To provide estimates for utility scores and EQ-5D Visual Analog Scale (VAS) for patients with AR or asthma | ||
520 | |a METHODS: We conducted a cross-sectional study using direct patient data from the MASK-air® app on European MASK-air® users with self-reported AR or asthma. We used a multiattribute instrument (EQ-5D) to measure quality-of-life (as utility scores and EQ-5D VAS values). Mean scores were calculated per country and disease control level using multilevel regression models with post-stratification, accounting for age and sex biases | ||
520 | |a RESULTS: We assessed data from up to 7905 MASK-air® users reporting a total of up to 82,737 days. For AR, utilities ranged from 0.86-0.99 for good control versus 0.72-0.85 for poor control; EQ-5D VAS levels ranged from 78.9-87.9 for good control versus 55.3-64.2 for poor control. For asthma, utilities ranged from 0.84-0.97 for good control versus 0.73-0.87 for poor control; EQ-5D VAS levels ranged from 68.4-81.5 for good control versus 51.4-64.2 for poor control. Poor disease control was associated with a mean loss of 0.14 utilities for both AR and asthma. For the same control levels, AR and asthma were associated with similar utilities and EQ-5D VAS levels. However, lower values were observed for asthma+AR when compared to AR alone | ||
520 | |a CONCLUSION: Poor AR or asthma control are associated with reduced quality-of-life. The estimates obtained from mHealth data may provide valuable insights for health technology assessment studies | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Allergic rhinitis | |
650 | 4 | |a Asthma | |
650 | 4 | |a EQ-5D-5L | |
650 | 4 | |a Health-related quality of life | |
650 | 4 | |a Mobile health | |
650 | 4 | |a Quality of life | |
650 | 4 | |a Real-world data | |
650 | 4 | |a Utilities | |
700 | 1 | |a Leemann, Lucas |e verfasserin |4 aut | |
700 | 1 | |a Briggs, Andrew |e verfasserin |4 aut | |
700 | 1 | |a Pereira, Ana Margarida |e verfasserin |4 aut | |
700 | 1 | |a Savouré, Marine |e verfasserin |4 aut | |
700 | 1 | |a Kuna, Piotr |e verfasserin |4 aut | |
700 | 1 | |a Morais-Almeida, Mário |e verfasserin |4 aut | |
700 | 1 | |a Bewick, Michael |e verfasserin |4 aut | |
700 | 1 | |a Azevedo, Luís Filipe |e verfasserin |4 aut | |
700 | 1 | |a Louis, Renaud |e verfasserin |4 aut | |
700 | 1 | |a Klimek, Ludger |e verfasserin |4 aut | |
700 | 1 | |a Bahbah, Farah |e verfasserin |4 aut | |
700 | 1 | |a Samolinski, Boleslaw |e verfasserin |4 aut | |
700 | 1 | |a Anto, Josep M |e verfasserin |4 aut | |
700 | 1 | |a Zuberbier, Torsten |e verfasserin |4 aut | |
700 | 1 | |a Fonseca, João A |e verfasserin |4 aut | |
700 | 1 | |a Bousquet, Jean |e verfasserin |4 aut | |
700 | 1 | |a Sousa-Pinto, Bernardo |e verfasserin |4 aut | |
700 | 0 | |a MASK-air think tank |e verfasserin |4 aut | |
700 | 1 | |a Czarlewski, Wienczyslawa |e investigator |4 oth | |
700 | 1 | |a Bedbrook, Anna |e investigator |4 oth | |
700 | 1 | |a Haahtela, Tari |e investigator |4 oth | |
700 | 1 | |a Canonica, G Walter |e investigator |4 oth | |
700 | 1 | |a Costa, Elisio M |e investigator |4 oth | |
700 | 1 | |a Kupczyk, Maciej |e investigator |4 oth | |
700 | 1 | |a Kvedariene, Violeta |e investigator |4 oth | |
700 | 1 | |a Kulus, Marek |e investigator |4 oth | |
700 | 1 | |a Larenas-Linnemann, Désirée E |e investigator |4 oth | |
700 | 1 | |a Pfaar, Oliver |e investigator |4 oth | |
700 | 1 | |a Papadopoulos, Nikolaos G |e investigator |4 oth | |
700 | 1 | |a Pham-Thi, Nhân |e investigator |4 oth | |
700 | 1 | |a Regateiro, Frederico S |e investigator |4 oth | |
700 | 1 | |a Roche, Nicolas |e investigator |4 oth | |
700 | 1 | |a Sastre, Joaquin |e investigator |4 oth | |
700 | 1 | |a Scichilone, Nicola |e investigator |4 oth | |
700 | 1 | |a Taborda-Barata, Luis |e investigator |4 oth | |
700 | 1 | |a Valiulis, Arunas |e investigator |4 oth | |
700 | 1 | |a Yorgancioglu, Arzu |e investigator |4 oth | |
700 | 1 | |a Ventura, Maria Teresa |e investigator |4 oth | |
700 | 1 | |a Almeida, Rute |e investigator |4 oth | |
700 | 1 | |a Amaral, Rita |e investigator |4 oth | |
700 | 1 | |a Ansotegui, Ignacio J |e investigator |4 oth | |
700 | 1 | |a Bergmann, Karl C |e investigator |4 oth | |
700 | 1 | |a Bosnic-Anticevich, Sinthia |e investigator |4 oth | |
700 | 1 | |a Braido, Fulvio |e investigator |4 oth | |
700 | 1 | |a Brussino, Luisa |e investigator |4 oth | |
700 | 1 | |a Cardona, Victoria |e investigator |4 oth | |
700 | 1 | |a Cecchi, Lorenzo |e investigator |4 oth | |
700 | 1 | |a Loureiro, Claudia Chaves |e investigator |4 oth | |
700 | 1 | |a Cingi, Cemal |e investigator |4 oth | |
700 | 1 | |a Cruz, Alvaro A |e investigator |4 oth | |
700 | 1 | |a Fokkens, Wytske J |e investigator |4 oth | |
700 | 1 | |a de Vries, Govert |e investigator |4 oth | |
700 | 1 | |a Gemicioglu, Bilun |e investigator |4 oth | |
700 | 1 | |a Giuliana, Antonio Fm |e investigator |4 oth | |
700 | 1 | |a Linuma, Tomohisa |e investigator |4 oth | |
700 | 1 | |a Ivancevich, Juan Carlos |e investigator |4 oth | |
700 | 1 | |a Jácome, Cristina |e investigator |4 oth | |
700 | 1 | |a Kaidashev, Igor |e investigator |4 oth | |
700 | 1 | |a Kraxner, Helga |e investigator |4 oth | |
700 | 1 | |a Laune, Daniel |e investigator |4 oth | |
700 | 1 | |a Louis, Gilles |e investigator |4 oth | |
700 | 1 | |a Lourenço, Olga |e investigator |4 oth | |
700 | 1 | |a Makela, Mika |e investigator |4 oth | |
700 | 1 | |a Makris, Michael |e investigator |4 oth | |
700 | 1 | |a Mösges, Ralph |e investigator |4 oth | |
700 | 1 | |a Maurer, Marcus |e investigator |4 oth | |
700 | 1 | |a Mullol, Joaquim |e investigator |4 oth | |
700 | 1 | |a Nadif, Rachel |e investigator |4 oth | |
700 | 1 | |a Niedoszytko, Marek |e investigator |4 oth | |
700 | 1 | |a O'Hehir, Robyn |e investigator |4 oth | |
700 | 1 | |a Okamoto, Yoshitaka |e investigator |4 oth | |
700 | 1 | |a Ollert, Markus |e investigator |4 oth | |
700 | 1 | |a Olze, Heidi |e investigator |4 oth | |
700 | 1 | |a Patella, Vincenzo |e investigator |4 oth | |
700 | 1 | |a Pétré, Benoit |e investigator |4 oth | |
700 | 1 | |a Puggioni, Francesca |e investigator |4 oth | |
700 | 1 | |a Romantowski, Jan |e investigator |4 oth | |
700 | 1 | |a Rouadi, Philip W |e investigator |4 oth | |
700 | 1 | |a Reitsma, Sietze |e investigator |4 oth | |
700 | 1 | |a Rivero-Yeverino, Daniela |e investigator |4 oth | |
700 | 1 | |a Rodriguez-Gonzalez, Monica |e investigator |4 oth | |
700 | 1 | |a Sá-Sousa, Ana |e investigator |4 oth | |
700 | 1 | |a Serpa, Faradiba S |e investigator |4 oth | |
700 | 1 | |a Shamji, Mohamed H |e investigator |4 oth | |
700 | 1 | |a Sheikh, Aziz |e investigator |4 oth | |
700 | 1 | |a Ulrik, Charlotte Suppli |e investigator |4 oth | |
700 | 1 | |a Sofiev, Mikhail |e investigator |4 oth | |
700 | 1 | |a Sova, Milan |e investigator |4 oth | |
700 | 1 | |a Sperl, Annette |e investigator |4 oth | |
700 | 1 | |a Todo-Bom, Ana |e investigator |4 oth | |
700 | 1 | |a Tomazic, Peter V |e investigator |4 oth | |
700 | 1 | |a Toppila-Salmi, Sanna |e investigator |4 oth | |
700 | 1 | |a Tsiligianni, Ioanna |e investigator |4 oth | |
700 | 1 | |a Valovirta, Erkka |e investigator |4 oth | |
700 | 1 | |a van Eerd, Michiel |e investigator |4 oth | |
700 | 1 | |a Zidarn, Mihaela |e investigator |4 oth | |
700 | 1 | |a Blain, Hubert |e investigator |4 oth | |
700 | 1 | |a Boulet, Louis-Philippe |e investigator |4 oth | |
700 | 1 | |a Brusselle, Guy |e investigator |4 oth | |
700 | 1 | |a Buhl, Roland |e investigator |4 oth | |
700 | 1 | |a Charpin, Denis |e investigator |4 oth | |
700 | 1 | |a Casale, Thomas |e investigator |4 oth | |
700 | 1 | |a Chivato, Tomas |e investigator |4 oth | |
700 | 1 | |a Correia-de-Sousa, Jaime |e investigator |4 oth | |
700 | 1 | |a Corrigan, Christopher |e investigator |4 oth | |
700 | 1 | |a de Blay, Frédéric |e investigator |4 oth | |
700 | 1 | |a Del Giacco, Stefano |e investigator |4 oth | |
700 | 1 | |a Devillier, Philippe |e investigator |4 oth | |
700 | 1 | |a Dykewicz, Mark |e investigator |4 oth | |
700 | 1 | |a Fiocchi, Alessandro |e investigator |4 oth | |
700 | 1 | |a Giovannini, Mattia |e investigator |4 oth | |
700 | 1 | |a Jassem, Ewa |e investigator |4 oth | |
700 | 1 | |a Jutel, Marek |e investigator |4 oth | |
700 | 1 | |a Keil, Thomas |e investigator |4 oth | |
700 | 1 | |a La Grutta, Stefania |e investigator |4 oth | |
700 | 1 | |a Lipworth, Brian |e investigator |4 oth | |
700 | 1 | |a Papi, Alberto |e investigator |4 oth | |
700 | 1 | |a Pépin, Jean-Louis |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t The journal of allergy and clinical immunology. In practice |d 2013 |g (2024) vom: 30. März |w (DE-627)NLM227247523 |x 2213-2201 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:30 |g month:03 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jaip.2024.03.036 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 30 |c 03 |